Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Relationship between medication adherence and treatment outcomes: the COMBINE study.

Zweben A, Pettinati HM, Weiss RD, Youngblood M, Cox CE, Mattson ME, Gorroochurn P, Ciraulo D.

Alcohol Clin Exp Res. 2008 Sep;32(9):1661-9. doi: 10.1111/j.1530-0277.2008.00743.x.

2.

Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response.

Gueorguieva R, Wu R, Krystal JH, Donovan D, O'Malley SS.

Addict Behav. 2013 May;38(5):2119-27. doi: 10.1016/j.addbeh.2013.01.024.

3.

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group..

JAMA. 2006 May 3;295(17):2003-17.

PMID:
16670409
4.

Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.

Donovan DM, Anton RF, Miller WR, Longabaugh R, Hosking JD, Youngblood M; COMBINE Study Research Group..

J Stud Alcohol Drugs. 2008 Jan;69(1):5-13.

PMID:
18080059
5.

Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.

Greenfield SF, Pettinati HM, O'Malley S, Randall PK, Randall CL.

Alcohol Clin Exp Res. 2010 Oct;34(10):1803-12. doi: 10.1111/j.1530-0277.2010.01267.x.

6.

Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention?

Doggrell SA.

Expert Opin Pharmacother. 2006 Oct;7(15):2169-73.

PMID:
17020440
7.
8.

Does family history of alcoholism moderate naltrexone's effects on alcohol use?

Capone C, Kahler CW, Swift RM, O'Malley SS.

J Stud Alcohol Drugs. 2011 Jan;72(1):135-40.

PMID:
21138720
9.

Cravings as a mediator and moderator of drinking outcomes in the COMBINE study.

Subbaraman MS, Lendle S, van der Laan M, Kaskutas LA, Ahern J.

Addiction. 2013 Oct;108(10):1737-44. doi: 10.1111/add.12238.

10.

Modeling longitudinal drinking data in clinical trials: an application to the COMBINE study.

DeSantis SM, Bandyopadhyay D, Baker NL, Randall PK, Anton RF, Prisciandaro JJ.

Drug Alcohol Depend. 2013 Sep 1;132(1-2):244-50. doi: 10.1016/j.drugalcdep.2013.02.013.

12.

Baseline trajectories of heavy drinking and their effects on postrandomization drinking in the COMBINE Study: empirically derived predictors of drinking outcomes during treatment.

Gueorguieva R, Wu R, Donovan D, Rounsaville BJ, Couper D, Krystal JH, O'Malley SS.

Alcohol. 2012 Mar;46(2):121-31. doi: 10.1016/j.alcohol.2011.08.008.

13.

Self-efficacy change as a mediator of associations between therapeutic bond and one-year outcomes in treatments for alcohol dependence.

Hartzler B, Witkiewitz K, Villarroel N, Donovan D.

Psychol Addict Behav. 2011 Jun;25(2):269-78. doi: 10.1037/a0022869.

14.

Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.

Mann K, Lemenager T, Hoffmann S, Reinhard I, Hermann D, Batra A, Berner M, Wodarz N, Heinz A, Smolka MN, Zimmermann US, Wellek S, Kiefer F, Anton RF; PREDICT Study Team..

Addict Biol. 2013 Nov;18(6):937-46. doi: 10.1111/adb.12012.

PMID:
23231446
15.
16.

Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study.

Weiss RD, O'malley SS, Hosking JD, Locastro JS, Swift R; COMBINE Study Research Group..

J Stud Alcohol Drugs. 2008 Nov;69(6):878-84.

17.

Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study.

Ray LA, Oslin DW.

Drug Alcohol Depend. 2009 Dec 1;105(3):256-8. doi: 10.1016/j.drugalcdep.2009.07.006.

18.

Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.

Zarkin GA, Bray JW, Aldridge A, Mitra D, Mills MJ, Couper DJ, Cisler RA; COMBINE Cost-Effectiveness Research Group..

Arch Gen Psychiatry. 2008 Oct;65(10):1214-21. doi: 10.1001/archpsyc.65.10.1214.

19.

The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis.

Donoghue K, Elzerbi C, Saunders R, Whittington C, Pilling S, Drummond C.

Addiction. 2015 Jun;110(6):920-30. doi: 10.1111/add.12875. Review.

PMID:
25664494
20.

Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials.

Falk D, Wang XQ, Liu L, Fertig J, Mattson M, Ryan M, Johnson B, Stout R, Litten RZ.

Alcohol Clin Exp Res. 2010 Dec;34(12):2022-34. doi: 10.1111/j.1530-0277.2010.01290.x.

PMID:
20659066
Items per page

Supplemental Content

Support Center